252 related articles for article (PubMed ID: 11810302)
41. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
[TBL] [Abstract][Full Text] [Related]
42. [Relationship between Q192R polymorphisms in paraoxonase 1 gene and young ischemic stroke].
Liu JL; Li JP; Wang XL; Yang Y
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):912-6. PubMed ID: 20646512
[TBL] [Abstract][Full Text] [Related]
43. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
[TBL] [Abstract][Full Text] [Related]
44. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
[TBL] [Abstract][Full Text] [Related]
45. Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries.
Najafi M; Gohari LH; Firoozrai M
Thromb Res; 2009; 123(3):503-10. PubMed ID: 18433845
[TBL] [Abstract][Full Text] [Related]
46. Investigation of PON1 192 and PON1 55 polymorphisms in ovarian cancer patients in Turkish population.
Arpaci A; Görmüs U; Dalan B; Berkman S; Isbir T
In Vivo; 2009; 23(3):421-4. PubMed ID: 19454508
[TBL] [Abstract][Full Text] [Related]
47. Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
Uyar OA; Kara M; Erol D; Ardicoglu A; Yuce H
Genet Mol Res; 2011 Feb; 10(1):133-9. PubMed ID: 21308654
[TBL] [Abstract][Full Text] [Related]
48. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
49. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
[TBL] [Abstract][Full Text] [Related]
50. Association of oxidative stress and paraoxonase status with PROCAM risk score.
Stefanović A; Kotur-Stevuljević J; Spasić S; Vekic J; Bujisić N
Clin Biochem; 2009 May; 42(7-8):617-23. PubMed ID: 19318033
[TBL] [Abstract][Full Text] [Related]
51. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
Akçay YD; Sagin FG; Sendağ F; Oztekin K; Sozmen EY
Maturitas; 2006 Feb; 53(3):325-32. PubMed ID: 16023312
[TBL] [Abstract][Full Text] [Related]
52. Genetic association between single nucleotide polymorphisms in the paraoxonase 1 (PON1) gene and small-for-gestational-age birth in related and unrelated subjects.
Infante-Rivard C
Am J Epidemiol; 2010 May; 171(9):999-1006. PubMed ID: 20375196
[TBL] [Abstract][Full Text] [Related]
53. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.
Paré G; Ross S; Mehta SR; Yusuf S; Anand SS; Connolly SJ; Fox KA; Eikelboom JW
Circ Cardiovasc Genet; 2012 Apr; 5(2):250-6. PubMed ID: 22368149
[TBL] [Abstract][Full Text] [Related]
54. Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.
Araki S; Makita Y; Canani L; Ng D; Warram JH; Krolewski AS
Diabetologia; 2000 Dec; 43(12):1540-3. PubMed ID: 11151764
[TBL] [Abstract][Full Text] [Related]
55. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.
Leus FR; Wittekoek ME; Prins J; Kastelein JJ; Voorbij HA
Atherosclerosis; 2000 Apr; 149(2):371-7. PubMed ID: 10729387
[TBL] [Abstract][Full Text] [Related]
56. Paraoxonase 1 mutations in a Turkish population.
Aynacioglu AS; Cascorbi I; Mrozikiewicz PM; Nacak M; Tapanyigit EE; Roots I
Toxicol Appl Pharmacol; 1999 Jun; 157(3):174-7. PubMed ID: 10373401
[TBL] [Abstract][Full Text] [Related]
57. The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects.
Hassan MA; Al-Attas OS; Hussain T; Al-Daghri NM; Alokail MS; Mohammed AK; Vinodson B
Mol Cell Biochem; 2013 Aug; 380(1-2):121-8. PubMed ID: 23625196
[TBL] [Abstract][Full Text] [Related]
58. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers.
Albers JW; Garabrant DH; Berent S; Richardson RJ
J Expo Sci Environ Epidemiol; 2010 Jan; 20(1):79-89. PubMed ID: 19223938
[TBL] [Abstract][Full Text] [Related]
59. [Paraoxonase 1 gene Gln192Arg polymorphism in and Alzheimer disease].
He XM; Zhang ZX; Zhang JW; Zhou YT; Tang MN; Wu CB; Hong Z
Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):270-3. PubMed ID: 16780669
[TBL] [Abstract][Full Text] [Related]
60. Relationship between the paraoxonase 1 gene glutamine 192 to arginine polymorphism and gestational diabetes mellitus in Saudi women.
Al-Hakeem MM; Abotalib Z; Alharbi KK; Khan IA
Clin Biochem; 2014 Oct; 47(15):122-5. PubMed ID: 25036896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
